Moderna submitted authorization application for its COVID-19 vaccine in adolescents in Switzerland
On Jun. 14, 2021, Moderna announced that it had submitted an authorization application to Swissmedic for use of…
-
-
Novavax COVID-19 vaccine demonstrated 90% overall efficacy and 100% protection in phase 3 trial
On Jun. 14, 2021, Novavax announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against…
-
Cocrystal’s COVID-19 antiviral CDI-45205 shown to be active against SARS-CoV-2 and prominent SARS-CoV-2 variants
On Jun. 14, 2021, Cocrystal Pharma announced that its lead preclinical SARS-CoV-2 3CL protease inhibitor CDI-45205 is active…
-
G7 announced pledges of 870 million COVID-19 vaccine doses
On Jun. 13, 2021, in a landmark agreement at G7 summit, held in Cornwall, UK, global leaders have…
-
Quidel received amended Emergency Use Authorization for new Sofia Q rapid antigen test device
On Jun. 11, 2021, Quidel announced today that it had received an amended Emergency Use Authorization (EUA) from…
-
Moderna and Tabuk Pharmaceuticals partnered to commercialize COVID-19 Vaccine in Saudi Arabia
On Jun. 11, 2021, Moderna and and Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial…
-
FDA issued EUA for the Janssen COVID-19 vaccine manufactured at Emergent BioSolutions facility in Baltimore
On Jun. 11, 2021, The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
-
Novavax announces positive data from three complementary studies of COVID-19 Beta variant strain vaccine
On Jun. 11, 2021, Novavax announced preclinical and clinical data on the company’s original recombinant protein COVID-19 vaccine…
-
Pfizer and BioNTech provided 500 million doses of COVID-19 vaccine to U.S. Government for donation to poorest nations
On Jun. 10, 2021, Pfizer and BioNTech announced plans to provide the U.S. government at a not-for-profit price…
-
Moderna filed for Emergency Use Authorization for its COVID-19 vaccine in adolescents in the United States
On Jun. 10, 2021, Moderna announced that it had requested an emergency use authorization (EUA) for its COVID-19…
-
Merck announced supply agreement with U.S. Government for molnupiravir, an Investigational oral antiviral treatment of COVID-19
On Jun. 9, 2021, Merck announced it had entered into a procurement agreement with the United States government…
-
Roche obtained CE mark for SARS-CoV-2 antigen self test nasal allowing for rapid self testing of COVID-19 at home
On Jun. 8, 2021, Roche announced it had received CE mark for its SARS-CoV-2 Antigen Self Test Nasal…
-
RECOVERY trial found aspirin does not improve survival for patients hospitalised with COVID-19
On Jun. 8, 2021, the University of Oxford announced the RECOVERY trial was established as a randomised clinical…
-
Twist Bioscience began shipping of synthetic RNA controls for Kappa (B.1.617.1) SARS-CoV-2 variants
On Jun. 8, 2021, Twist Bioscience announced that it has started shipping its synthetic RNA reference controls for…
-
Senolytics reduced COVID-19 symptoms in preclinical studies
On Jun. 8, 2021, Mayo Clinic researchers and colleagues at the University of Minnesota showed that COVID-19 exacerbates…
-
Pixel by Labcorp COVID-19 PCR test home collection kits now available nationwide
On Jun. 8, 2021, LabCorp announced that its Pixel COVID-19 PCR Test Home Collection Kits were availavle in…
-
INOVIO expanded partnership with Advaccine to conduct global phase 3 efficacy trial of COVID-19 DNA vaccine candidate
On Jun. 8, 2021, Inovio Pharma announced an expansion of its previously announced partnership with Advaccine Biopharmaceuticals to…
-
Moderna applied for EU coronavirus vaccine authorization covering teens
On Jun. 7, 2021, Moderna announced announced that it had submitted for a variation to the conditional marketing…
-
Moderna and Medison Pharma partnered to commercialize COVID-19 vaccine in Central Eastern Europe and Israel
On Jun. 7, 2021, Moderna announced a new agreement to commercialize its COVID-19 Vaccine across Central Eastern Europe…
-
OraSure Technologies receives three EUA’s for its COVID-19 rapid antigen tests for non-prescription use
On Jun. 7, 2021, OraSure Technologies announced that it had received Emergency Use Authorization (EUA) from the U.S….
-
FDA authorized lower 1,200 mg intravenous and subcutaneous dose of REGEN-COV antibody cocktail to treat COVID-19 patients
On Jun. 4, 2021, Regeneron announced the U.S. Food and Drug Administration (FDA) updated the Emergency Use Authorization…
-
Innovation Pharma completed enrollment in phase 2 clinical trial for COVID-19
On Jun. 3, 2021, Innovation Pharma announced that it had achieved full patient enrollment in its randomized, double-blind,…
-
Moderna announced agreement to supply the Republic of Botswana with COVID-19 vaccine
On Jun. 3, 2021, Moder’s vaccine against COVID-19, to support the government’s ongoing efforts to secure access to…
-
Resverlogix and EVERSANA announced partnership to support commercialization of Apabetalone for COVID-19 in U.S. and Canada
On Jun. 3, 2021, Resverlogix announced a partnership to support planned commercialization of apabetalone in the United States…
-
NIH researchers identified potential new antiviral drug for COVID-19
On Jun. 3, 2021, the National Institutes of Health (NIH) announced that the experimental drug TEMPOL may be…
-
Lonza and Moderna announced collaboration for drug substance manufacturing of COVID-19 Vaccine in the Netherlands
On Jun. 2, 2021, Lonza announced the expansion of its collaboration with Moderna. The expanded collaboration extended the…
-
Relief Therapeutics reported that NRx Pharma, had submitted an application for EUA for Aviptadil to the U.S. FDA
On Jun. 2, 2021, NRx Pharmaceuticals announced it had filed an application with U.S. Food and Drug Administration…
-
UNICEF and Moderna announced long term agreement to supply vaccine on behalf of the COVAX facility
On Jun. 2, 2021, UNICEF announced it had signed a long-term agreement with Moderna for the supply of COVID-19 vaccine on behalf of the…
-
Vaxxas and collaborators revealed potential of Vaxxas’ high-density microarray patch to deliver SARS-CoV-2 vaccine
On Jun. 2, 2021, Vaxxas announced that research demonstrated the potential of Vaxxas’ novel high-density microarray patch (HD-MAP)…
-
U.S. blood donations declared safe under current COVID-19 screening guidelines
On Jun. 1, 2021, a study by researchers at the National Institutes of Health and their colleagues found…
